Kindstar's Lab Work in China Carries Challenges – A Businessweek Article

Baird Capital Partners Asia portfolio company Wuhan Kindstar Diagnostics does lab work for more than 2,000 hospitals in 320 cities across China, charging $50 to $300 per test. Last year, the startup added 700 new hospitals as clients, and it expects to keep growing fast as more Chinese enter the middle class and can afford tests to diagnose cancers and other diseases that in the past often went undetected and untreated.

Read the full article on Businessweek.com.